8:00 - 10:00 AM
Badge Pickup & Exhibit Setup
9:00 - 10:00 AM
Georgia Life Sciences Showcase & Rapid Fire Research Showcase
Hear Georgia-based companies who are developing or have bioscience/medtech related products present their technology.
COMPANY SHOWCASE
9:00AM – Cambium Oncology, Gary Altman
9:10AM – PERSOWN, Eric Doherty
9:20AM – Andson Biotech, Bram Frankel
9:30AM – Zeeva Therapeutics, Shiva Arjunon
9:40AM – Ovum Medical, Matthew White
9:50AM – EnOPrep, Austin Tull
RAPID FIRE RESEARCH SHOWCASE
9:00AM – Eric Miller, 5-Fluorouracil-Based Therapies to Treat Colorectal Cancer
9:10AM – Kasie Collins, Platform Enabling Extended Release of Protein-based Therapeutics
9:20AM – Shafiq Khan, Novel Anti-Metastatic Agents
9:30AM – Chunhui Xu, Small molecules against chemotherapy-induced cardiotoxicity
9:40AM – Ramaraja Ramasamy, Rapid Diagnostic Tool for Food Borne Pathogen
9:50AM – Nicole Pribut, Lysophospholipid-Derived Prodrugs of TFV as next-gen Antivirals
10:00 - 11:00 AM
Plenary: Patients, Policy & Politics: How Life Sciences is a Key Priority for Georgia & Patients
From investments in workforce and STEM infrastructure at our colleges and universities to securing an “essential” designation for life science companies during the pandemic, Georgia Bio’s policy and advocacy work keeps Georgia’s life science industry thriving.
This session will kick off with remarks from incoming GRA President & CEO, Dr. Tim Denning on the critical relationship between industry and academia; and preview his vision for GRA. Dr. Denning will be followed by a conversation with PhRMA and patient leaders discussing a key industry priority…Policies to Help Patients Pay Less for their Medicines.
Dr. Denning's remarks will be followed by a panel discussion on a key industry priority…Share the Savings.
Americans want policymakers to see lowering out-of-pocket costs for health care as a top priority. In 2021, West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and their PBMs to share the savings they negotiate on medicines directly with patients. This legislation serves as a roadmap for other states looking to help lower costs for patients. Join us for a lively conversation to learn how this commonsense policy could help lower what patients pay out of pocket by hundreds of dollars a year. And learn how you can help make this happen in Georgia.
Speakers
-
Welcome – Maria Thacker-Goethe
-
Presenting Sponsor Remarks – The Honorable Mayor Rusty Paul
-
Plenary Presentation Introduction: Steve Damon, CEO, Micron Biomedical, Inc.; Georgia Bio Chair
-
Plenary Presentation: Timothy L. Denning, Ph.D., President & CEO, Georgia Research Alliance (GRA)
-
Patients, Policy & Politics: How Life Sciences is a Key Priority for Georgia & Patients
-
Dorothy Leone-Glasser,RN,HHC, Executive Director of the Advocates for Responsible Care
-
Zachary Poss, Director - State Advocacy, PhRMA
-
The Honorable Rep. Deborah Silcox (R)
-
Moderator: Jenee' Burke, Director, State Government Relations & Public Affairs, UCB
-
11:00 AM - 12:00 PM
Plenary: Putting the Tech in Bio/MedTech: The Intersection of Software and Science
Georgia is a global leader in software and data sciences as well as next generation life science fields such as cell therapy, protein engineering, and antibody therapeutics. The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. Hear from leaders building the next generation of companies at the intersection of AI/ML, computational biology, and life sciences.
Speakers
-
Michel van Musschenbroek, Field Marketing Manager, MilliporeSigma
-
Patricia Obermaier, Chief Growth Officer, Global Health and Life Sciences, Microsoft
-
Joseph (Robby) Robertson, Product and Technology Lead, US Neurology, UCB
-
Moderator: Dr. Joe Sutherland, Director, Center for AI Learning, Emory University
12:00 - 1:30 PM
Networking Lunch / Exhibit Hall
1:30 - 3:00 PM
Plenary: Dr. Ted W. Love, Former President & CEO of Global Blood Therapeutics; 2023-2025 Board Chair, Biotechnology Innovation Organization
-
Anthony Shuker Scientific Poster Awards, Announcement of Poster Winners
-
BioReady Communities Lauch: Maria Thacker-Goethe & The Honorable Mayor John Bradberry
-
‘Put Patients at the Center of Biotech” - Dr. Ted W. Love, Former President & CEO of Global Blood Therapeutics; 2023-2025 Board Chair, Biotechnology Innovation Organization
-
Fireside Chat with Dr. Love Moderated by: Greg Vaughn, MD, Senior Advisor, GRA; Partner, Spencer Stuart
3:00 - 4:00 PM
Networking / Exhibit Hall
Georgia Life Sciences Showcase & Rapid Fire Research Showcase
Hear Georgia-based companies who are developing or have bioscience/medtech related products present their technology.
COMPANY SHOWCASE
3:00PM - Annoviant, Ajay Houde
3:10PM – Hub Hygiene, Jud Ready
3:20PM – Atherovax, Amir Khan
3:30PM – Nutrivert, Horace Nalle
3:40PM - Strike Photonics, Tripp Hardy
3:50PM – Kinemo, Nordine Sebkhi
RAPID FIRE RESEARCH SHOWCASE
3:00PM – Daqing Wu, Novel small-molecule therapy for advanced prostate cancer
3:10PM – Darren Browning, Gut-targeted Phosphodiesterase inhibitors for intestinal diseases.
3:20PM – Delta Ghoshal, Cell Therapy Potency Metric
3:30PM – Ming Luo, Vesta Biomedicals
3:40PM – Joshua Luke, TrueAngel Healthcare Group
3:50PM – Jaroslava Halper, Diagnostic assays for equine degenerative suspensory desmitis
4:00 - 5:15 PM
Plenary: Launching and Funding a Company in a Challenging Environment: Investors' Perspectives of Best Practices and Critical Errors
Launching a life science company requires thousands of “make it or break it” decisions around developing the science, building the team, and financing the business. Additionally, we have gone from one of the strongest environments to one of the more challenging. This panel of seasoned investors will discuss best practices and critical errors companies make in building a capital stack from founding through acquisition as well as how those decisions influence an investor’s interest in investing at each stage and the impact on the company’s valuation. This panel will also dive into how the funding landscape for life science companies has transformed dramatically over the past 24 months.
Powered by Life Sciences Nation & Radyus Research
Speakers
-
Justin Burns, PhD, Biotech/Healthcare Venture Capital at Morningside
-
Matt Goldman, Partner, J2 Ventures
-
Joshua Eckelberry, Principal, SOLAS BioVentures
-
Steven Lehmann, Director, Venture Operations, Portal Innovations
-
Moderator: Marta New, PhD, MBA, CEO, Radyus Research
-
RESI South Announcement: Erika Wu, Business Development Manager, Global Tech Hubs and Southeast USA BD, Life Science Nation
-
GA Life Sciences Company Showcase Winners Announced
-
Closing Remarks, Steve Damon, CEO, Micron Biomedical, Inc.; Georgia Bio Chair
5:15 - 6:30 PM